A Pilot Study to Assess the Activity of Demethylation Therapy in Patients With HPV Positive Compared With HPV Negative Head and Neck Squamous Cell Carcinoma (HNSCC)

Trial Profile

A Pilot Study to Assess the Activity of Demethylation Therapy in Patients With HPV Positive Compared With HPV Negative Head and Neck Squamous Cell Carcinoma (HNSCC)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Jan 2018

At a glance

  • Drugs Azacitidine (Primary)
  • Indications Head and neck cancer; Squamous cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 12 Jan 2018 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top